DJIA 18,010.68 -115.44 -0.64%
NASDAQ 5,070.03 -27.95 -0.55%
S&P 500 2,107.39 -13.40 -0.63%
market minute promo

163.84 -2.35 (-1.41%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

ALXN $163.84 -1.41%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $165.59
Previous Close $166.19
Daily Range $162.27 - $166.66
52-Week Range $150.06 - $203.30
Market Cap $32.7B
P/E Ratio 56.91
Dividend (Yield) $0.00 (0.0%)
Volume 1,723,976
Average Daily Volume 2,338,052
Current FY EPS $4.82




Drug Makers

Alexion Pharmaceuticals, Inc. (ALXN) Description

A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions. Website:

News & Commentary Rss Feed

Why I'm Buying Sarepta Therapeutics Stock

Sarepta Therapeutics got some great news from the FDA yesterday that sent shares soaring. Here's why the stock is definitely worth a deeper dive by risk-tolerant investors.

QLD, ALXN, AAL, ADI: ETF Outflow Alert

Short Sellers Get Even More Ambitious Against Biotech Leaders

Synageva BioPharma Files for Kanuma's Approval in Japan - Analyst Blog

New Strong Sell Stocks for May 26th - Tale of the Tape

'Fast Money' Recap: This Stock Has Risen Every Summer for the Past Decade

Why I Bought The Dips In Both Gilead And Achillion Today

Consolidation Is Good - Cramer's Mad Money (5/18/15)

Biotech Stock Roundup: Alexion to Buy Synageva, FDA Panel Backs Vertex's Orkambi - Analyst Blog

Short Sellers Start to Get Nervous on Biotech

See More ALXN News...

ALXN's Top Competitors

ALXN $163.84 (-1.41%)
Current stock: ALXN
AMGN $156.26 (-0.69%)
Current stock: AMGN
GILD $112.27 (-0.51%)
Current stock: GILD
BIIB $396.99 (-0.78%)
Current stock: BIIB